Aller au contenu principal
Accès ouvert déclaré 2026 article

Impact of Extraction Recovery and Matrix Effect on qPCR-based Biodistribution Analysis in Gene Therapy: Strategies for Mitigation

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

In DNA biodistribution studies, genomic DNA (gDNA) is commonly used as a normalizer for quantifying vector DNA (vDNA) to account for multiple variations including tissue type, sample input, DNA extraction efficiency, etc. Typically, the concentrations of both vDNA and gDNA in elution buffer after extraction are interpolated from standard curves prepared in neat solution, and the derived vector genome per diploid genome (vg/dg) ratio is reported to represent the relative amount of delivered vDNA in tissues. However, the accuracy of this interpolated vg/dg relies on the assumption that vDNA and gDNA have equal extraction efficiencies and are similarly affected by the tissue matrix during qPCR quantification. Despite its widespread use operationally, this assumption has yet to be scientifically examined. In this work, we tested this assumption by co-spiking vDNA and gDNA into the same tissue samples, then conducting DNA extraction and qPCR analysis to compare their extraction recovery and matrix effect. Our results revealed that vDNA and gDNA exhibit differential recovery even from the same sample and are affected differently by the tissue matrix. Consequently, this leads to bias in the interpolation of sample vg/dg values. We proposed and developed two strategies to mitigate the impact of recovery and matrix effect on DNA biodistribution studies: (1) using a matching matrix curve that closely resembles the study samples, and (2) optimizing the DNA extraction protocol to minimize the recovery and matrix effect differences. These strategies have been successfully applied to multiple biodistribution studies. We believe these findings provide valuable insights that enhance the accuracy and reliability of DNA biodistribution analysis in gene therapy research.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Impact of Extraction Recovery and Matrix Effect on qPCR-based Biodistribution Analysis in Gene Therapy: Strategies for Mitigation
Date Crossref
18/09/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Biogen (United States) pays non établi dans la notice
    Entreprise
  • Drug Metabolism and Pharmacokinetics pays non établi dans la notice
    Institution
  • USA. long.yuan@biogen.com MA pays non établi dans la notice
    Organisation à but non lucratif

Biogen (United States), Drug Metabolism and Pharmacokinetics et MA — USA. long.yuan@biogen.com.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Virus-based gene therapy researchMolecular Biology Techniques and ApplicationsRNA Interference and Gene Delivery

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.